Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 6/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | CCNC | P24863 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17812843 | 0.95 | CYP11B1 (0.44) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17812862 | 0.92 | PRKCZ (0.38) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17812839 | 0.91 | CYP11B1 (0.47) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17805233 | 0.87 | PRKCZ (0.43) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL30640166 | 0.87 | PRKCZ (0.43) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17812865 | 0.86 | CYP11B1 (0.46) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17805215 | 0.85 | CYP11B1 (0.33) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL17812867 | 0.85 | NPC1 (0.39) | PIK3CDPIK3CAMTORNPC1ALDH1A1 | |
| SCHEMBL17812840 | 0.83 | PRKCZ (0.46) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL19529190 | 0.83 | KDM4E (0.44) | CYP1A2CYP2D6CYP2C9CYP2C19PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-9842999-B2 | Benzotriazole derivative and an organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| US-9842999-B2 | Benzotriazole derivative and an organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| WO-2016111254-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 保土谷化学工業株式会社 | 2016-07-14 | — | — | WO | disclosed |
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | AHR, SLC18A1, KCNH1 | CYP11B1 272/4885CYP11B2 470/4885CYP3A4 136/4885 |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, KCNH1 | CYP11B1 272/4885CYP11B2 470/4885CYP3A4 136/4885 |
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | AHR, ARNT, NAT1 | CYP11B1 668/4885CYP11B2 556/4885CYP3A4 897/4885 |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, ARNT | CYP11B1 450/4885CYP11B2 394/4885CYP3A4 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.